EXHIBIT 8
Dr. Reddy’s Laboratories Limited
Dr. Reddy’s Laboratories Limited is the parent company. Tabulated below is the list of subsidiaries, joint ventures and associates as of March 31, 2025:
Name of the subsidiaries/associates/joint ventures |
| Country of Incorporation |
| Percentage of Direct/Indirect Ownership Interest |
Aurigene Discovery Technologies (Malaysia) Sdn. Bhd. |
| Malaysia |
| 100%(1) |
Aurigene Oncology Limited (formerly, Aurigene Discovery Technologies Limited) |
| India |
| 100% |
Aurigene Pharmaceutical Services Limited |
| India |
| 100%(1) |
beta Institute gemeinnützige GmbH |
| Germany |
| 100%(6) |
betapharm Arzneimittel GmbH |
| Germany |
| 100%(6) |
Cheminor Employees Welfare Trust |
| India |
| Refer to below footnote(12) |
Cheminor Investments Limited |
| India |
| 100% |
Chirotech Technology Limited (dissolved on September 18, 2024). |
| United Kingdom |
| 100% |
Clean Renewable Energy KK 2A Private Limited (from July 31, 2024) |
| India |
| 26.99%(10) |
Dr. Reddy’s (Beijing) Pharmaceutical Co. Limited |
| China |
| 100%(7) |
Dr. Reddy’s and Nestlé Health Science Limited (formerly, Dr. Reddy’s Nutraceuticals Limited) (refer note 36.A for details) |
| India |
| 51%(15) |
Dr. Reddy’s Bio-Sciences Limited |
| India |
| 100% |
Dr. Reddy’s Employees ESOS Trust |
| India |
| Refer to below footnote(12) |
Dr. Reddy’s Farmaceutica Do Brasil Ltda. |
| Brazil |
| 100% |
Dr. Reddy’s Finland Oy (from December 20, 2024) |
| Finland |
| 100%(7) |
Dr. Reddy’s Formulations Limited |
| India |
| 100% |
Dr. Reddy’s Laboratories (Australia) Pty. Limited |
| Australia |
| 100%(7) |
Dr. Reddy’s Laboratories (EU) Limited |
| United Kingdom |
| 100%(7) |
Dr. Reddy’s Laboratories (Proprietary) Limited |
| South Africa |
| 100%(7) |
Dr. Reddy’s Laboratories (Thailand) Limited |
| Thailand |
| 100%(7) |
Dr. Reddy’s Laboratories (UK) Limited |
| United Kingdom |
| 100%(3) |
Dr. Reddy’s Laboratories Canada, Inc. |
| Canada |
| 100%(7) |
Dr. Reddy’s Laboratories Chile SPA. |
| Chile |
| 100%(7) |
Dr. Reddy’s Laboratories Inc. |
| U.S.A. |
| 100%(7) |
Dr. Reddy’s Laboratories Jamaica Limited (from September 25,2023) |
| Jamaica |
| 100%(7) |
Dr. Reddy’s Laboratories Japan KK |
| Japan |
| 100%(7) |
Dr. Reddy’s Laboratories Kazakhstan LLP |
| Kazakhstan |
| 100%(7) |
Dr. Reddy’s Laboratories LLC |
| Russia |
| 100%(7) |
Dr. Reddy’s Laboratories LLC, Ukraine |
| Ukraine |
| 100%(7) |
Dr. Reddy’s Laboratories Louisiana LLC (divested on March 21, 2025) |
| U.S.A. |
| 100%(4) |
Dr. Reddy’s Laboratories Malaysia Sdn. Bhd. |
| Malaysia |
| 100%(7) |
Dr. Reddy’s Laboratories New York, LLC |
| U.S.A. |
| 100%(4) |
Dr. Reddy’s Laboratories Philippines Inc. |
| Philippines |
| 100%(7) |
Dr. Reddy’s Laboratories Romania Srl |
| Romania |
| 100%(7) |
Dr. Reddy’s Laboratories SA |
| Switzerland |
| 100% |
Dr. Reddy’s Laboratories SAS |
| Colombia |
| 100%(7) |
Dr. Reddy’s Laboratories Taiwan Limited |
| Taiwan |
| 100%(7) |
Dr. Reddy’s New Zealand Limited. |
| New Zealand |
| 100%(7) |
Dr. Reddy’s Research Foundation |
| India |
| Refer to below footnote(12) |
Dr. Reddy’s Srl |
| Italy |
| 100%(8) |
Dr. Reddy’s Venezuela, C.A. (dissolved on June 5, 2024) |
| Venezuela |
| 100% |
Dr. Reddy's Denmark ApS (from October 4, 2024) |
| Denmark |
| 100%(7) |
Dr. Reddy's Netherlands B.V. (formerly Dr.Reddy’s Research and Development B.V.) |
| Netherlands |
| 100%(9) |
DRES Energy Private Limited |
| India |
| 26%(10) |
DRL Impex Limited |
| India |
| 100%(11) |
Idea2Enterprises (India) Pvt. Limited |
| India |
| 100% |
Imperial Owners and Land Possessions Private Limited (Formerly, Imperial Credit Private Limited) (entity under liquidation) |
| India |
| 100% |
Industrias Quimicas Falcon de Mexico, S.A. de CV |
| Mexico |
| 100% |
Kunshan Rotam Reddy Medicine Company Limited |
| China |
| 51.33%(2)(10)(14) |
Kunshan Rotam Reddy Pharmaceutical Co. Limited |
| China |
| 51.33%(2)(10) |
Lacock Holdings Limited |
| Cyprus |
| 100%(7) |
Nimbus Health GmbH |
| Germany |
| 100%(6) |
North Star OpCo Limited (from September 30, 2024) |
| United Kingdom |
| 100%(13) |
North Star Sweden AB (from September 30, 2024) |
| Sweden |
| 100%(13) |
Northstar Switzerland SARL (from September 30, 2024) |
| Switzerland |
| 100%(7) |
O2 Renewable Energy IX Private Limited |
| India |
| 26%(10) |
Promius Pharma LLC |
| U.S.A. |
| 100%(4) |
Reddy Holding GmbH |
| Germany |
| 100%(7) |
Reddy Netherlands B.V. |
| Netherlands |
| 100%(7) |
Reddy Pharma Iberia SAU |
| Spain |
| 100%(7) |
Reddy Pharma Italia S.R.L. |
| Italy |
| 100%(5) |
Reddy Pharma SAS |
| France |
| 100%(7) |
Svaas Wellness Limited |
| India |
| 100% |
(1) | Indirectly owned through Aurigene Oncology Limited (Formerly, Aurigene Discovery Technologies Limited). |
(2) | Kunshan Rotam Reddy Pharmaceutical Co. Limited and Kunshan Rotam Reddy Medicine Company Limited are subsidiaries as per Indian Companies Act, 2013, as the Company holds a 51.33% stake. However, the Company accounts for this investment by the equity method and does not consolidate it in the Company’s financial statements. |
(3) | Indirectly owned through Dr. Reddy’s Laboratories (EU) Limited. |
(4) | Indirectly owned through Dr. Reddy’s Laboratories Inc. |
(5) | Indirectly owned through Lacock Holdings Limited. |
(6) | Indirectly owned through Reddy Holding GmbH. |
(7) | Indirectly owned through Dr. Reddy’s Laboratories SA. |
(8) | Indirectly owned through Reddy Pharma Italia S.R.L. |
(9) | Indirectly owned through Reddy Netherlands B.V. |
(10) | Accounted using equity method as per IAS 28, “Investment in Associates and Joint Ventures”. |
(11) | Indirectly owned through Idea2Enterprises (India) Pvt. Limited. |
(12) | The Company does not have any equity interests in this entity but has significant influence or control over it. |
(13) | Indirectly owned through North Star Switzerland SARL. |
(14) | Indirectly owned through Kunshan Rotam Reddy Pharmaceutical Co. Limited. |